What is the severity of CVE-2018-14787?

CVE-2018-14787 is considered a high-severity vulnerability due to the potential for arbitrary code execution by an authenticated user.

How do I fix CVE-2018-14787?

To mitigate CVE-2018-14787, upgrade Philips IntelliSpace Cardiovascular to version 3.1 or later and Philips Xcelera to version 4.2 or later.

Who is affected by CVE-2018-14787?

CVE-2018-14787 affects users of Philips IntelliSpace Cardiovascular versions 2.x and prior, and Philips Xcelera versions 4.1 and prior.

What are the potential impacts of CVE-2018-14787?

Exploitation of CVE-2018-14787 could allow an attacker with escalated privileges to execute arbitrary code on affected systems.

How can an attacker exploit CVE-2018-14787?

An attacker can exploit CVE-2018-14787 by gaining elevated privileges to access executable folders and leveraging write permissions to execute malicious code.

Vulnerability/
CVE-2018-14787

high

7.8

CWE

269

14/8/2018

5/8/2024

CVE-2018-14787

First published: Tue Aug 14 2018(Updated: )

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.

Credit: ics-cert@hq.dhs.gov

Affected Software	Affected Version	How to fix
Philips IntelliSpace Cardiovascular	<=3.1
Philips Xcelera	<=4.1

Never miss a vulnerability like this again

Reference Links

Frequently Asked Questions

What is the severity of CVE-2018-14787?
CVE-2018-14787 is considered a high-severity vulnerability due to the potential for arbitrary code execution by an authenticated user.
How do I fix CVE-2018-14787?
To mitigate CVE-2018-14787, upgrade Philips IntelliSpace Cardiovascular to version 3.1 or later and Philips Xcelera to version 4.2 or later.
Who is affected by CVE-2018-14787?
CVE-2018-14787 affects users of Philips IntelliSpace Cardiovascular versions 2.x and prior, and Philips Xcelera versions 4.1 and prior.
What are the potential impacts of CVE-2018-14787?
Exploitation of CVE-2018-14787 could allow an attacker with escalated privileges to execute arbitrary code on affected systems.
How can an attacker exploit CVE-2018-14787?
An attacker can exploit CVE-2018-14787 by gaining elevated privileges to access executable folders and leveraging write permissions to execute malicious code.

collector/nvd-index
agent/references
agent/type
agent/softwarecombine
collector/mitre-cve
source/MITRE
agent/author
agent/weakness
agent/last-modified-date
agent/severity
agent/tags
agent/description
agent/event
agent/first-publish-date
agent/source
vendor/philips
canonical/philips intellispace cardiovascular
version/philips intellispace cardiovascular/3.1
canonical/philips xcelera
version/philips xcelera/4.1

Company

Resources

Contact

SecAlerts Pty Ltd.
132 Wickham Terrace
Fortitude Valley,
QLD 4006, Australia
info@secalerts.co

By using SecAlerts services, you agree to our services end-user license agreement. This website is safeguarded by reCAPTCHA and governed by the Google Privacy Policy and Terms of Service. All names, logos, and brands of products are owned by their respective owners, and any usage of these names, logos, and brands for identification purposes only does not imply endorsement. If you possess any content that requires removal, please get in touch with us.